Apedia

Technology Concerns Recombinant Dna Medicine Companies Genetic Engineering

Concerns surrounding RDT in medicine include restricted access to vital technologies due to proprietary rights and ethical debates about potential applications like creating 'designer babies'.

Concerns in medicine include restricted access to life-saving technologies due to patents and ethical dilemmas surrounding potential misuse for traits like 'designer babies'.

Front Concerns with use of Recombinant DNA technology in medicine
Back Companies that own genetic engineering technologies may limit the use of technologies that could be life saving

Some people worry this technology could be used unethically (designer babies)

Learn with these flashcards. Click next, previous, or up to navigate to more flashcards for this subject.

Next card: Humanitarian benefits recombinant dna technology agriculturally reduce risk

Previous card: Insulin recombinant dna technology medicine treat type diabetes

Up to card list: AQA Biology Flashcards